MEDICAL INNOVATION POWERING THE FUTURE OF PATIENT CARE
The DELTA HEALTH GROUP is an international healthcare conglomerate with a diversified portfolio spanning across four core strategic pillars:
The DELTA HEALTH GROUP is an international healthcare conglomerate with a diversified portfolio spanning across four core strategic pillars:
MISSION & VISION
MISSION & VISION
Established more than two decades ago, the DELTA HEALTH GROUP has built and operates a very efficient network of proprietary clinical trial investigative sites across the United States, along with strategic partnerships with other prominent hospitals and medical centers around the world. Over the years, the organization has steadily evolved, strengthening its expertise in successfully leading United States Food and Drug Administration (FDA)-compliant innovative clinical drug development programs and expanding its global footprint in international healthcare
Driven by a passion for connecting medical innovations with patients, diseases, and treatments, DELTA HEALTH partners across the healthcare ecosystem to optimize and develop novel drugs, biologics, and medical devices—advancing therapies and improving patient care.
INTERNATIONAL TELEMEDICINE
Overcoming the barriers of distance and resource limitations, the DELTA HEALTH teams of distinguished physicians and surgeons have been providing personalized specialist care for patients from assigned geographic regions around the world.
EXPERTISE IN LATE STAGE CLINICAL DEVELOPMENT
MEDICAL INNOVATION OUR "A-TEAM"
MEDICAL INNOVATION OUR "A-TEAM"
Backed by a proven track record spanning more than 20 years, the highly experienced, best-in-class specialty providers of the DELTA HEALTH “A-Team” have pioneered breakthrough medical innovations and led full clinical development programs that have culminated in the successful regulatory approval of multiple prescription drug products by the United States FDA and Health Canada.
A number of these drugs are being used to treat patients in the United States, Canada and other countries around the world.
The DELTA HEALTH “A-Team” employs a pragmatic,hands-on approach, providing full end-to-end oversight and disciplined execution of clinical trials across the entire development lifecycle. This comprehensive model is central to the success of our clinical programs and clearly differentiates us from global competitors.
WHAT DIFFERENTIATES US FROM OTHERS
WHAT DIFFERENTIATES US FROM OTHERS
Over two decades of in-person, face-to-face interactions and successful working collaboration with various Therapeutic Area Divisions of the United States FDA for clinical phase programs related to drugs, biologics and medical devices has significantly strengthened our expertise in late stage clinical development.
This direct engagement with the US FDA has positioned us among a select group within the healthcare industry and provided a distinct advantage over others—deepening our understanding and strengthening our ability to successfully direct FDA clinical development programs for partner companies.
CLINICAL TRIAL INVESTIGATIVE SITES
CLINICAL TRIAL INVESTIGATIVE SITES
"Running clinical trials where patient populations are located"
DELTA HEALTH operates a global network of dedicated and strategically located clinical trial investigative sites—that know how to deliver results.
Utilizing proprietary patient databases and advanced AI-driven tools to support rapid enrollment and operational scale-up across multiple regions, these premier, multi-specialty investigative sites—including large state-of-the-art hospital-based centers in Türkiye—have extensive experience in conducting Phase 1, Phase 2 and pivotal Phase 3 clinical trials.
Backed by modern central labs, these clinical sites are directly managed by highly skilled, on-the-ground specialists from DELTA HEALTH whose expertise has been consistently vetted over time by various therapeutic area divisions of the United States FDA.
Operating in compliance with rigorous international guidelines, a number of these clinical trial sites have successfully passed inspections conducted by the US FDA.
DELTA HEALTH
US FDA SEASONED & VETTED CLINICAL TRIAL SITE TEAMS
OUR UNRELENTING COMMITMENT TO EXCELLENCE
OUR UNRELENTING COMMITMENT TO EXCELLENCE
Combining a patient-centric approach with an unrelenting commitment to excellence, our expertise in developing and executing end-to-end US FDA new drug development programs and managing global clinical trial sites is built on deep knowledge and hands-on experience acquired from working directly with the FDA and successfully directing numerous Phase 1 through pivotal Phase 3 studies across more than 1,000 clinical programs for drugs, biologics, and medical devices.
Our partner bioanalytical laboratory has successfully passed inspections by the U.S. FDA and Health Canada, demonstrating its adherence to the highest standards of quality, compliance and regulatory excellence.
Our extensive experience with the U.S. FDA enables us to understand exactly what is required for the success of individual clinical development programs. This insight is particularly valuable in managing studies conducted under the direct supervision of the DELTA HEALTH teams on the ground at our strategically located clinical trial investigative sites.
With an acquired acumen for the US FDA clinical drug development process, the DELTA HEALTH team is a dependable partner to co-develop investigational medical products and advance them through the development cycle to successful regulatory approval.
CROSS-FUNCTIONAL GLOBAL TEAMS
CROSS-FUNCTIONAL GLOBAL TEAMS
The DELTA HEALTH global teams include dedicated clinical drug development professionals, clinical trial physician investigators and study site management experts
The clinical development and clinical trial site teams have deep knowledge of legislation and broad based experience of the healthcare industry giving them the flexibility to work in major regions around the world.
The DELTA HEALTH International Telemedicine Division includes U.S. Board Certified Medical and Surgical Specialists, U.K. General Medical Council Specialists and other therapeutic area physicians.
Our Advisory Board includes prestigious names in the world of medicine, including physicians on the faculty of major hospitals and university medical centers in the United States, Canada, Türkiye and the United Kingdom
To complement our international medical teams, DELTA HEALTH is supported by experts from the Advanced Medical Solutions Division
GET IN TOUCH
GET IN TOUCH
